.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Post-Conference Perspectives: Impact of TAILORx in Choosing Adjuvant Therapy in Early Breast Cancer

EP. 1: Oncotype DX in Early Stage Breast Cancer

April 1st 2020

EP. 2: Early Stage Breast Cancer: TAILORx Trial

April 1st 2020

EP. 3: TAILORx 2019 Exploratory Analysis and SEER Data

April 1st 2020

EP. 4: Role of the Oncotype DX Breast Recurrence Score Test

April 1st 2020

EP. 5: Impact of the TAILORx Trial on BC Management

April 1st 2020

EP. 6: BC-Specific Mortality in Patients 50 Years Old or Younger

April 1st 2020

EP. 7: How Has Genomic Testing Impacted the BC Treatment Landscape?

April 1st 2020

EP. 8: Oncotype DX Testing and the TAILORx Trial

April 1st 2020

EP. 9: The Impact of Genomic Testing on mBC Treatment

April 1st 2020